tradingkey.logo
tradingkey.logo
Search

US FDA approves J&J's immune disorder drug

ReutersApr 30, 2025 12:35 PM
facebooktwitterlinkedin
View all comments0

- The U.S. Food and Drug Administration has approved Johnson & Johnson's JNJ.N drug to treat patients aged 12 years and older with an immune-mediated disorder, the drugmaker said on Wednesday.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI